Baker Avenue Asset Management, LP Sorrento Therapeutics, Inc. Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $63,500 - $100,000	-10,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $15,700 - $47,600	10,000 New	10,000 $18,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $14,500 - $41,700	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.86 - $5.94 $18,600 - $59,400	10,000 New	10,000 $47,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.